Cancer

Oncology

Regulation optimisation could save thousands of life years

Embracing a “once-in-a-generation opportunity” to improve access to oncology treatments could save thousands of years of life across the European Union.

Oncology

Using bispecific antibodies to advance cancer immunotherapy

Dr Laura Moriarty, senior marketing manager at Bio-Rad, looks at the impressive immuno-therapeutic potential of bispecific antibodies (bsAbs).

Events

Partner Content

Next Generation CAR-TCR Summit

Engineering Smarter Adoptive Cell Therapies

News

COVID-19 and cancer: can pharma stymie the pandemic’s impact on mortality?

England's cancer therapy backlog 'could take more than a dec...

A new report has suggested it could take until 2033 to clear the backlog of cancer treatment in England caused by the pandemic.

White Papers

How pharma can help the post-COVID recovery of European canc...

The new Cancer Care in Europe: Recovering from COVID-19 Disruption white paper assesses the disruption to patient care and the changes physicians i

R&D

Targeting COVID-19 and cancer with immunotherapy advancement...

Anna Biosciences’ Dr Anthony Rullo discusses the drug development company’s immunotherapy platform.